COLUMBIA, S.C., Oct. 24 (UPI) -- Eli Lilly has agreed to pay South Carolina a record $45 million to settle a dispute over the marketing of the anti-psychotic drug Zyprexa, officials say.
INDIANAPOLIS, June 24 (UPI) -- Eli Lilly and Co. says the U.S. Food and Drug Administration has extended the review period for the experimental blood thinner prasugrel.
ANCHORAGE, Alaska, March 12 (UPI) -- A former U.S. drug regulator testified at a trial in Alaska Monday that Eli Lilly tried to minimize the negative aspects of the drug Zyprexa.
INDIANAPOLIS, June 12 (UPI) -- Indianapolis-based drug giant Eli Lilly and Co. said Tuesday it settled 900 more product liability claims against its top-selling drug Zyprexa.
INDIANAPOLIS, Dec. 21 (UPI) -- Eli Lilly provided doctors information about Zyprexa's blood sugar risks that conflicted with earlier internal documents, company documents showed.
JACKSON, Miss., July 25 (UPI) -- Mississippi has filed a legal action against Eli Lilly and Co. alleging a plan to defraud the state of millions of dollars in Medicaid reimbursements.
INDIANAPOLIS, Dec. 22 (UPI) -- The Indianapolis-based Eli Lilly & Co. has reportedly agreed to pay a $36 million fine for off-label promotion of its Evista osteoporosis treatment.
INDIANAPOLIS, Dec. 8 (UPI) -- Eli Lilly & Co. of Indianapolis announced a Web site Wednesday on which it will post clinical trial results for many of its top-selling drugs.
INDIANAPOLIS, Dec. 29 (UPI) -- The Food and Drug Administration has approved for sale an Indianapolis pharmaceutical company's treatment for bipolar depression.
INDIANAPOLIS, May 8 (UPI) -- Eli Lilly and Co. Wednesday investigated suspected tampering involving its schizophrenia drug, Zyprexa, after several pharmacists in Minnesota and Wisconsin fou
